Pfizer and Allergan to Combine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
Pfizer (PFE) And Allergan (AGN) Could Trade 'Range-Bound', Says Deutsche Bank
November 23, 2015 1:57 PM ESTShares of Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) could be 'range-bound' for some time, according to Deutsche Bank analyst Gregg Gilbert. Comments follow news the two companies reached a $160 billion merger agreement.
"Conceptually, we could see both stocks remaining range-bound for some time (close expected in 2H16) as investors of various types consider the merits of the transaction," said Gilbert."This deal, if closed, will make PFE an... More

